Benzinga's Top Initiations
Analysts at Wunderlich initiated coverage on Medifast Inc (NYSE: MED) with a Hold rating. The target price for Medifast is set to $32. Medifast shares closed at $28.68 on Thursday.
Analysts at Guggenheim Securities initiated coverage on Dynegy Inc. (NYSE: DYN) with a Neutral rating. Dynegy shares closed at $11.37 on Thursday.
SunTrust Robinson Humphrey initiated coverage on Kite Pharma Inc (NASDAQ: KITE) with a Buy rating. The target price for Kite Pharma is set to $70. Kite Pharma shares closed at $44.85 on Thursday.
Analysts at BMO Capital initiated coverage of Parsley Energy Inc (NYSE: PE) with a Outperform rating. Parsley Energy shares closed at $19.11 on Thursday.
Analysts at Benchmark initiated coverage on STAAR Surgical Company (NASDAQ: STAA) with a Hold rating. STAAR Surgical shares closed at $6.47 on Thursday.
Analysts at Barrington Research initiated coverage on ICF International Inc (NASDAQ: ICFI) with a Market Perform rating. ICF International shares closed at $32.63 on Thursday.
RBC Capital initiated coverage of American Equity Investment Life Holding (NYSE: AEL) with a Outperform rating. The target price for American Equity Investment Life Holding is set to $24. American Equity Investment Life Holding shares closed at $17.37 on Thursday.
BMO Capital initiated coverage on Diamondback Energy Inc (NASDAQ: FANG) with a Outperform rating. Diamondback Energy shares closed at $72.79 on Thursday.
Citigroup initiated coverage on Taylor Morrison Home Corp (NYSE: TMHC) with a Neutral rating. Taylor Morrison Home shares closed at $11.55 on Thursday.
Analysts at Wunderlich initiated coverage on NutriSystem Inc. (NASDAQ: NTRI) with a Buy rating. The target price for NutriSystem is set to $25. NutriSystem shares closed at $18.95 on Thursday.
Latest Ratings for MED
Date | Firm | Action | From | To |
---|---|---|---|---|
Jan 2021 | DA Davidson | Maintains | Buy | |
Nov 2020 | DA Davidson | Upgrades | Neutral | Buy |
Jun 2020 | B. Riley FBR | Initiates Coverage On | Buy |
View More Analyst Ratings for MED
View the Latest Analyst Ratings
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Top InitiationsInitiation Analyst Ratings